Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Dexmedetomidine pretreatment alleviates ropivacaine-induced neurotoxicity via the miR-10b-5p/BDNF axis

Fig. 2

Dexmedetomidine pretreatment suppressed miR-10b-5p expression. A-B miR-10b-5p expression in HT22 and SH-SY5Y cells under different treatments was detected using RT-qPCR. The cell experiment was repeated 3 times independently. Data are presented as mean ± standard deviation. Data in panels A-B were analyzed using one-way ANOVA, followed by Tukey's multiple comparisons test, *p < 0.05

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us